Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Paul J. Maddon currently holds 909,891 shares of PROGENICS PHARMACEUTICALS INC (PGNX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Paul J. Maddon has been a net seller of PGNX stock. They have purchased $306.8K and sold $11.9M worth of shares.
Paul J. Maddon's most recent insider trade was on Dec 1, 2010, when they purchased 5,000 shares at $4.90 per share.
Paul J. Maddon serves as Executive at PROGENICS PHARMACEUTICALS INC (PGNX). They have executed 148 insider transactions totaling $12.2M over their tenure at the company.
Paul J. Maddon holds the position of Executive at PROGENICS PHARMACEUTICALS INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Paul J. Maddon has shown a selling trading pattern, with $306.8K in total purchases and $11.9M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Paul J. Maddon was on Oct 15, 2007, when they sold $352.4K worth of PGNX shares. This transaction involved 15,000 shares at $23.49 per share.
Paul J. Maddon currently owns 909,891 shares of PROGENICS PHARMACEUTICALS INC (PGNX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Paul J. Maddon's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Paul J. Maddon has 148 Form 4 filings on record as an insider at PROGENICS PHARMACEUTICALS INC.
Set alerts for Paul J. Maddon and 40,000+ other insiders.